With 9.25% Distance From Low, Is 4D Molecular Therapeutics Inc (NASDAQ:FDMT) Still Renewed For Growth?
In last trading session, 4D Molecular Therapeutics Inc (NASDAQ:FDMT) saw 0.31 million shares changing hands with its beta currently measuring 2.68. Company’s recent per share